FRAT1 expression and its correlation with pathologic grade, proliferation, and apoptosis in human astrocytomas

Medical Oncology

Volumn 28, Issue 1, 2011, Pages 1-6

  Guo, Geng ^a   Liu, Bolin ^a   Zhong, Chengliang ^b   Zhang, Xiang ^a   Mao, Xinggang ^a   Wang, Peng ^a   Jiang, Xiaofan ^a   Huo, Junli ^a   Jin, Ji ^c   Liu, Xiaodong ^c   Chen, Xiaoyan ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c SHANXI MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Astrocytoma; FRAT1; Immunohistochemistry; Proliferation; TUNEL

Indexed keywords

FREQUENTLY REARRANGED IN ADVANCED T CELL LYMPHOMAS 1; KI 67 ANTIGEN; TUMOR MARKER; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; APOPTOSIS; ARTICLE; ASTROCYTOMA; CANCER GRADING; CELL PROLIFERATION; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; NICK END LABELING; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; TUMOR GROWTH;

ADOLESCENT; ADULT; AGED; APOPTOSIS; ASTROCYTOMA; BRAIN NEOPLASMS; CELL PROLIFERATION; CHILD; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; PROGNOSIS; PROTO-ONCOGENE PROTEINS; YOUNG ADULT;

EID: 79952246428     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12032-009-9402-x     Document Type: Article

References (27)

1. JC Buckner PD Brown BP O'Neill FB Meyer CJ Wetmore JH Uhm 2007 Central nervous system tumors Mayo Clin Proc 82 1271 1286 17908533 10.4065/82.10.1271 (Pubitemid 47502884)
2. LM DeAngelis 2001 Brain tumors N Engl J Med 344 114 123 11150363 10.1056/NEJM200101113440207 1:STN:280:DC%2BD3M7ksVWjtQ%3D%3D (Pubitemid 32052502)
3. MJ van den Bent ME Hegi R Stupp 2006 Recent developments in the use of chemotherapy in brain tumours Eur J Cancer 42 582 588 16427778 10.1016/j.ejca.2005.06.031 (Pubitemid 43343679)
4. T Saitoh M Katoh 2001 FRAT1 and FRAT2, clustered in human chromosome 10q24.1 region, are up-regulated in gastric cancer Int J Oncol 19 311 315 11445844 1:CAS:528:DC%2BD3MXlslSmt7o%3D
5. C Yost GH Farr 3rd SB Pierce DM Ferkey MM Chen D Kimelman 1998 GBP, an inhibitor of GSK-3, is implicated in Xenopus development and oncogenesis Cell 93 1031 1041 9635432 10.1016/S0092-8674(00)81208-8 1:CAS:528:DyaK1cXjvFKqsb4%3D (Pubitemid 28280796)
6. DM Ferkey D Kimelman 2002 Glycogen synthase kinase-3 beta mutagenesis identifies a common binding domain for GBP and Axin J Biol Chem 277 16147 16152 11861647 10.1074/jbc.M112363200 1:CAS:528:DC%2BD38Xjs1Wjtbo%3D (Pubitemid 34967901)
7. T Hagen DA Cross AA Culbert A West S Frame N Morrice AD Reith 2006 FRAT1, a substrate-specific regulator of glycogen synthase kinase-3 activity, is a cellular substrate of protein kinase A J Biol Chem 281 35021 35029 16982607 10.1074/jbc.M607003200 1:CAS:528:DC%2BD28XhtF2gtbnF (Pubitemid 46036541)
8. T Saitoh T Mine M Katoh 2002 Molecular cloning and expression of proto-oncogene FRAT1 in human cancer Int J Oncol 20 785 789 11894125 1:CAS:528:DC%2BD38XislOqsr8%3D
9. J Jonkers HC Korswagen D Acton M Breuer A Berns 1997 Activation of a novel proto-oncogene, Frat1, contributes to progression of mouse T-cell lymphomas EMBO J 16 441 450 9034327 10.1093/emboj/16.3.441 1:CAS:528: DyaK2sXisVyms7g%3D (Pubitemid 27067774)
10. J Jonkers JJ Weening M van der Valk R Bobeldijk A Berns 1999 Overexpression of Frat1 in transgenic mice leads to glomerulosclerosis and nephrotic syndrome, and provides direct evidence for the involvement of Frat1 in lymphoma progression Oncogene 18 5982 5990 10557087 10.1038/sj.onc.1202995 1:CAS:528:DyaK1MXntlGitLY%3D (Pubitemid 29535010)
11. Y Wang SM Hewitt S Liu X Zhou H Zhu C Zhou G Zhang L Quan J Bai N Xu 2006 Tissue microarray analysis of human FRAT1 expression and its correlation with the subcellular localisation of beta-catenin in ovarian tumours Br J Cancer 94 686 691 16479254 1:CAS:528:DC%2BD28XitVyjtr8%3D (Pubitemid 43361900)
12. Q Wei Y Zhao ZQ Yang QZ Dong XJ Dong Y Han C Zhao EH Wang 2008 Dishevelled family proteins are expressed in non-small cell lung cancer and function differentially on tumor progression Lung Cancer 62 181 192 18692936 10.1016/j.lungcan.2008.06.018
13. W Remmele U Hildebrand HA Hienz PJ Klein M Vierbuchen LJ Behnken B Heicke E Scheidt 1986 Comparative histological, histochemical, immunohistochemical and biochemical studies on oestrogen receptors, lectin receptors, and Barr bodies in human breast cancer Virchows Arch A Pathol Anat Histopathol 409 127 147 2424168 10.1007/BF00708323 1:STN:280:DyaL283jslSrsg%3D%3D (Pubitemid 16084979)
14. M Sanson J Thillet K Hoang-Xuan 2004 Molecular changes in gliomas Curr Opin Oncol 16 607 613 15627025 10.1097/01.cco.0000142485.81849.cc 1:CAS:528:DC%2BD2cXhtVOqt7bJ (Pubitemid 39482982)
15. CY Logan R Nusse 2004 The Wnt signaling pathway in development and disease Annu Rev Cell Dev Biol 20 781 810 15473860 10.1146/annurev.cellbio.20. 010403.113126 1:CAS:528:DC%2BD2cXhtVejsr7I (Pubitemid 39488658)
16. H Clevers 2006 Wnt/beta-catenin signaling in development and disease Cell 127 469 480 17081971 10.1016/j.cell.2006.10.018 1:CAS:528:DC%2BD28Xht1WhtbbN (Pubitemid 44647433)
17. RT Moon AD Kohn GV De Ferrari A Kaykas 2004 WNT and beta-catenin signalling: diseases and therapies Nat Rev Genet 5 691 701 15372092 10.1038/nrg1427 1:CAS:528:DC%2BD2cXnt12nt7g%3D (Pubitemid 39150127)
18. RH Giles JH van Es H Clevers 2003 Caught up in a Wnt storm: Wnt signaling in cancer Biochim Biophys Acta 1653 1 24 12781368 1:CAS:528: DC%2BD3sXktFWmur8%3D (Pubitemid 36627817)
19. E Fraser N Young R Dajani J Franca-Koh J Ryves RS Williams M Yeo MT Webster C Richardson MJ Smalley LH Pearl A Harwood TC Dale 2002 Identification of the Axin and Frat binding region of glycogen synthase kinase-3 J Biol Chem 277 2176 2185 11707456 10.1074/jbc.M109462200 1:CAS:528:DC%2BD38XosFeluw%3D%3D (Pubitemid 34968804)
20. L Li H Yuan CD Weaver J Mao GH Farr 3rd DJ Sussman J Jonkers D Kimelman D Wu 1999 Axin and Frat1 interact with dvl and GSK, bridging Dvl to GSK in Wnt-mediated regulation of LEF-1 EMBO J 18 4233 4240 10428961 10.1093/emboj/18.15.4233 1:CAS:528:DyaK1MXlt1GqsL0%3D (Pubitemid 29364125)
21. A Salic E Lee L Mayer MW Kirschner 2000 Control of beta-catenin stability: reconstitution of the cytoplasmic steps of the wnt pathway in Xenopus egg extracts Mol Cell 5 523 532 10882137 10.1016/S1097-2765(00)80446-3 1:CAS:528:DC%2BD3cXisVWrs70%3D
22. NS Tolwinski E Wieschaus 2004 Rethinking WNT signaling Trends Genet 20 177 181 15041171 10.1016/j.tig.2004.02.003 1:CAS:528:DC%2BD2cXisVGitb4%3D (Pubitemid 38369188)
23. P Polakis 2000 Wnt signaling and cancer Genes Dev 14 1837 1851 10921899 1:CAS:528:DC%2BD3cXls1yqsbc%3D (Pubitemid 30639518)
24. J Behrens JP von Kries M Kuhl L Bruhn D Wedlich R Grosschedl W Birchmeier 1996 Functional interaction of beta-catenin with the transcription factor LEF-1 Nature 382 638 642 8757136 10.1038/382638a0 1:CAS:528:DyaK28XltValtLg%3D (Pubitemid 26268958)
25. S Pelengaris M Khan G Evan 2002 c-MYC: more than just a matter of life and death Nat Rev Cancer 2 764 776 12360279 10.1038/nrc904 1:CAS:528: DC%2BD38XnsVGrtbw%3D (Pubitemid 37328911)
26. Y Wang S Liu H Zhu W Zhang G Zhang X Zhou C Zhou L Quan J Bai L Xue N Lu N Xu 2008 FRAT1 overexpression leads to aberrant activation of beta-catenin/TCF pathway in esophageal squamous cell carcinoma Int J Cancer 123 561 568 18498136 10.1002/ijc.23600 1:CAS:528:DC%2BD1cXotVyhsb8%3D (Pubitemid 351898413)
27. DR Hipfner SM Cohen 2004 Connecting proliferation and apoptosis in development and disease Nat Rev Mol Cell Biol 5 805 815 15459661 10.1038/nrm1491 1:CAS:528:DC%2BD2cXotVSlsrs%3D (Pubitemid 39336274)